JP2005508292A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508292A5 JP2005508292A5 JP2002591459A JP2002591459A JP2005508292A5 JP 2005508292 A5 JP2005508292 A5 JP 2005508292A5 JP 2002591459 A JP2002591459 A JP 2002591459A JP 2002591459 A JP2002591459 A JP 2002591459A JP 2005508292 A5 JP2005508292 A5 JP 2005508292A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- methyl
- ylidene
- benzamide
- diisopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 10
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims 3
- -1 CF 3 Chemical group 0.000 claims 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000002541 furyl group Chemical group 0.000 claims 2
- 125000002346 iodo group Chemical group I* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 125000001544 thienyl group Chemical group 0.000 claims 2
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical group NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 claims 1
- LVVTUSIQQJFKSG-UHFFFAOYSA-N 4-[(3-aminophenyl)-(1-benzylpiperidin-4-ylidene)methyl]-n,n-di(propan-2-yl)benzamide Chemical compound C1=CC(C(=O)N(C(C)C)C(C)C)=CC=C1C(C=1C=C(N)C=CC=1)=C1CCN(CC=2C=CC=CC=2)CC1 LVVTUSIQQJFKSG-UHFFFAOYSA-N 0.000 claims 1
- FCUFYGZDXREGDR-UHFFFAOYSA-N 4-[(3-aminophenyl)-[1-(1,3-thiazol-2-ylmethyl)piperidin-4-ylidene]methyl]-n,n-di(propan-2-yl)benzamide Chemical compound C1=CC(C(=O)N(C(C)C)C(C)C)=CC=C1C(C=1C=C(N)C=CC=1)=C1CCN(CC=2SC=CN=2)CC1 FCUFYGZDXREGDR-UHFFFAOYSA-N 0.000 claims 1
- GWCOLJIAYSEBGJ-UHFFFAOYSA-N 4-[(3-aminophenyl)-[1-(1h-imidazol-2-ylmethyl)piperidin-4-ylidene]methyl]-n,n-di(propan-2-yl)benzamide Chemical compound C1=CC(C(=O)N(C(C)C)C(C)C)=CC=C1C(C=1C=C(N)C=CC=1)=C1CCN(CC=2NC=CN=2)CC1 GWCOLJIAYSEBGJ-UHFFFAOYSA-N 0.000 claims 1
- XKUWGEDGGUNCNC-UHFFFAOYSA-N 4-[(3-aminophenyl)-[1-(1h-imidazol-5-ylmethyl)piperidin-4-ylidene]methyl]-n,n-di(propan-2-yl)benzamide Chemical compound C1=CC(C(=O)N(C(C)C)C(C)C)=CC=C1C(C=1C=C(N)C=CC=1)=C1CCN(CC=2N=CNC=2)CC1 XKUWGEDGGUNCNC-UHFFFAOYSA-N 0.000 claims 1
- SGFBRVPPNLSBRR-UHFFFAOYSA-N 4-[(3-aminophenyl)-[1-(furan-2-ylmethyl)piperidin-4-ylidene]methyl]-n,n-di(propan-2-yl)benzamide Chemical compound C1=CC(C(=O)N(C(C)C)C(C)C)=CC=C1C(C=1C=C(N)C=CC=1)=C1CCN(CC=2OC=CC=2)CC1 SGFBRVPPNLSBRR-UHFFFAOYSA-N 0.000 claims 1
- GPVPMCJYERJRDS-UHFFFAOYSA-N 4-[(3-aminophenyl)-[1-(furan-3-ylmethyl)piperidin-4-ylidene]methyl]-n,n-di(propan-2-yl)benzamide Chemical compound C1=CC(C(=O)N(C(C)C)C(C)C)=CC=C1C(C=1C=C(N)C=CC=1)=C1CCN(CC2=COC=C2)CC1 GPVPMCJYERJRDS-UHFFFAOYSA-N 0.000 claims 1
- HTALEWNNFQJXAO-UHFFFAOYSA-N 4-[(3-aminophenyl)-[1-(pyridin-2-ylmethyl)piperidin-4-ylidene]methyl]-n,n-di(propan-2-yl)benzamide Chemical compound C1=CC(C(=O)N(C(C)C)C(C)C)=CC=C1C(C=1C=C(N)C=CC=1)=C1CCN(CC=2N=CC=CC=2)CC1 HTALEWNNFQJXAO-UHFFFAOYSA-N 0.000 claims 1
- NCHDOXABXNSRNY-UHFFFAOYSA-N 4-[(3-aminophenyl)-[1-(pyridin-4-ylmethyl)piperidin-4-ylidene]methyl]-n,n-di(propan-2-yl)benzamide Chemical compound C1=CC(C(=O)N(C(C)C)C(C)C)=CC=C1C(C=1C=C(N)C=CC=1)=C1CCN(CC=2C=CN=CC=2)CC1 NCHDOXABXNSRNY-UHFFFAOYSA-N 0.000 claims 1
- UJYDPHJVZYKMHX-UHFFFAOYSA-N 4-[(3-aminophenyl)-[1-(thiophen-2-ylmethyl)piperidin-4-ylidene]methyl]-n,n-di(propan-2-yl)benzamide Chemical compound C1=CC(C(=O)N(C(C)C)C(C)C)=CC=C1C(C=1C=C(N)C=CC=1)=C1CCN(CC=2SC=CC=2)CC1 UJYDPHJVZYKMHX-UHFFFAOYSA-N 0.000 claims 1
- RLGLXNCCLQIKDA-UHFFFAOYSA-N 4-[(3-aminophenyl)-[1-(thiophen-3-ylmethyl)piperidin-4-ylidene]methyl]-n,n-di(propan-2-yl)benzamide Chemical compound C1=CC(C(=O)N(C(C)C)C(C)C)=CC=C1C(C=1C=C(N)C=CC=1)=C1CCN(CC2=CSC=C2)CC1 RLGLXNCCLQIKDA-UHFFFAOYSA-N 0.000 claims 1
- JWPQNSOKCGQNRI-UHFFFAOYSA-N 4-[(3-aminophenyl)-[1-[(4-bromophenyl)methyl]piperidin-4-ylidene]methyl]-n,n-di(propan-2-yl)benzamide Chemical compound C1=CC(C(=O)N(C(C)C)C(C)C)=CC=C1C(C=1C=C(N)C=CC=1)=C1CCN(CC=2C=CC(Br)=CC=2)CC1 JWPQNSOKCGQNRI-UHFFFAOYSA-N 0.000 claims 1
- UNQIZPYSMSJZNH-UHFFFAOYSA-N 4-[(3-aminophenyl)-[1-[(4-methoxyphenyl)methyl]piperidin-4-ylidene]methyl]-n,n-di(propan-2-yl)benzamide Chemical compound C1=CC(OC)=CC=C1CN(CC1)CCC1=C(C=1C=C(N)C=CC=1)C1=CC=C(C(=O)N(C(C)C)C(C)C)C=C1 UNQIZPYSMSJZNH-UHFFFAOYSA-N 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 208000027520 Somatoform disease Diseases 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000029936 alkylation Effects 0.000 claims 1
- 238000005804 alkylation reaction Methods 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 239000003054 catalyst Substances 0.000 claims 1
- 150000003840 hydrochlorides Chemical class 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- JMZFEHDNIAQMNB-UHFFFAOYSA-N m-aminophenylboronic acid Chemical compound NC1=CC=CC(B(O)O)=C1 JMZFEHDNIAQMNB-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000027753 pain disease Diseases 0.000 claims 1
- 229910052763 palladium Inorganic materials 0.000 claims 1
- 229940095064 tartrate Drugs 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001425 triazolyl group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101766A SE0101766D0 (sv) | 2001-05-18 | 2001-05-18 | Novel compounds |
| PCT/SE2002/000954 WO2002094786A1 (en) | 2001-05-18 | 2002-05-16 | 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508292A JP2005508292A (ja) | 2005-03-31 |
| JP2005508292A5 true JP2005508292A5 (enExample) | 2005-12-22 |
Family
ID=20284169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002591459A Pending JP2005508292A (ja) | 2001-05-18 | 2002-05-16 | ４−（フェニル−ピペリジン−４−イリデン−メチル）−ベンズアミド誘導体及び疼痛、不安症又は胃腸障害の治療のためのその使用 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7022715B2 (enExample) |
| EP (1) | EP1395559A1 (enExample) |
| JP (1) | JP2005508292A (enExample) |
| KR (1) | KR20040000468A (enExample) |
| CN (1) | CN1509271A (enExample) |
| AR (1) | AR033755A1 (enExample) |
| BG (1) | BG108327A (enExample) |
| BR (1) | BR0209677A (enExample) |
| CA (1) | CA2446155A1 (enExample) |
| CO (1) | CO5540303A2 (enExample) |
| CZ (1) | CZ20033086A3 (enExample) |
| EE (1) | EE200300527A (enExample) |
| HU (1) | HUP0401113A2 (enExample) |
| IL (1) | IL158703A0 (enExample) |
| IS (1) | IS7027A (enExample) |
| MX (1) | MXPA03010443A (enExample) |
| NO (1) | NO20035115D0 (enExample) |
| PL (1) | PL367214A1 (enExample) |
| RU (1) | RU2003131971A (enExample) |
| SE (1) | SE0101766D0 (enExample) |
| SK (1) | SK13962003A3 (enExample) |
| WO (1) | WO2002094786A1 (enExample) |
| ZA (1) | ZA200308634B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2319876T3 (es) | 2001-05-18 | 2009-05-14 | Astrazeneca Ab | Derivados de 4 (fenil-piperazinil-metil) benzamida y su uso para el tratamiento de la ansiedad o trastornos gastrointestinales. |
| SE0203303D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0203300D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0300104D0 (sv) * | 2003-01-16 | 2003-01-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| SE0300103D0 (sv) * | 2003-01-16 | 2003-01-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| SE0300105D0 (sv) * | 2003-01-16 | 2003-01-16 | Astrazeneca Ab | Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof |
| US20070099957A1 (en) * | 2003-05-16 | 2007-05-03 | Astra Zeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| US7338962B2 (en) | 2003-10-01 | 2008-03-04 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| SE0400026D0 (sv) * | 2004-01-09 | 2004-01-09 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| SE0401968D0 (sv) * | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| DK1781631T3 (da) | 2004-08-02 | 2012-05-14 | Astrazeneca Ab | Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf |
| US7598261B2 (en) | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| US7576207B2 (en) | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2898339A (en) | 1957-07-29 | 1959-08-04 | Wm S Merrell Co | N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine |
| US4581171A (en) | 1983-07-27 | 1986-04-08 | Janssen Pharmaceutica, N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders |
| US4816586A (en) | 1987-07-29 | 1989-03-28 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
| US5140029A (en) | 1989-01-09 | 1992-08-18 | Janssen Pharmaceutica N.V. | 2-aminopyrimidinone derivatives |
| US4939137A (en) | 1989-06-28 | 1990-07-03 | Ortho Pharmaceutical Corporation | Ring-fused thienopyrimidinedione derivatives |
| US5683998A (en) | 1991-04-23 | 1997-11-04 | Toray Industries, Inc. | Tricyclic triazolo derivatives, processes for producing the same and the uses of the same |
| GB9202238D0 (en) | 1992-02-03 | 1992-03-18 | Wellcome Found | Compounds |
| US5574159A (en) | 1992-02-03 | 1996-11-12 | Delta Pharmaceuticals, Inc. | Opioid compounds and methods for making therefor |
| SE9504661D0 (sv) | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| TW548271B (en) * | 1996-12-20 | 2003-08-21 | Astra Pharma Inc | Novel piperidine derivatives having an exocyclic double bond with analgesic effects |
| JP4754068B2 (ja) | 1997-12-24 | 2011-08-24 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | δ−オピオイドレセプターに結合する４−［アリール（ピペリジン−４−イル）］アミノベンズアミド類 |
| AU2001241676A1 (en) * | 2000-03-03 | 2001-09-17 | Ortho-Mcneil Pharmaceutical, Inc. | 3-(diarylmethylene)-8-azabicyclo(3.2.1)octane derivatives |
| US6556387B1 (en) * | 2000-03-31 | 2003-04-29 | Seagate Technology Llc | Controlling mechanical response characteristics of a disc drive actuator by adjusting a fastener engaging the actuator shaft to vary axial force on the bearing assembly |
| SE0001208D0 (sv) | 2000-04-04 | 2000-04-04 | Astrazeneca Canada Inc | Novel compounds |
| SE0001207D0 (sv) | 2000-04-04 | 2000-04-04 | Astrazeneca Canada Inc | Novel compounds |
-
2001
- 2001-05-18 SE SE0101766A patent/SE0101766D0/xx unknown
-
2002
- 2002-05-16 PL PL02367214A patent/PL367214A1/xx not_active Application Discontinuation
- 2002-05-16 CZ CZ20033086A patent/CZ20033086A3/cs unknown
- 2002-05-16 WO PCT/SE2002/000954 patent/WO2002094786A1/en not_active Ceased
- 2002-05-16 AR ARP020101811A patent/AR033755A1/es not_active Application Discontinuation
- 2002-05-16 HU HU0401113A patent/HUP0401113A2/hu unknown
- 2002-05-16 CN CNA028101863A patent/CN1509271A/zh active Pending
- 2002-05-16 BR BR0209677-3A patent/BR0209677A/pt not_active Application Discontinuation
- 2002-05-16 EP EP02771798A patent/EP1395559A1/en not_active Ceased
- 2002-05-16 US US10/477,851 patent/US7022715B2/en not_active Expired - Fee Related
- 2002-05-16 SK SK13962003A patent/SK13962003A3/sk unknown
- 2002-05-16 MX MXPA03010443A patent/MXPA03010443A/es unknown
- 2002-05-16 JP JP2002591459A patent/JP2005508292A/ja active Pending
- 2002-05-16 CA CA002446155A patent/CA2446155A1/en not_active Abandoned
- 2002-05-16 IL IL15870302A patent/IL158703A0/xx unknown
- 2002-05-16 RU RU2003131971/04A patent/RU2003131971A/ru not_active Application Discontinuation
- 2002-05-16 EE EEP200300527A patent/EE200300527A/xx unknown
- 2002-05-16 KR KR10-2003-7014942A patent/KR20040000468A/ko not_active Withdrawn
-
2003
- 2003-11-05 ZA ZA200308634A patent/ZA200308634B/en unknown
- 2003-11-07 BG BG108327A patent/BG108327A/bg unknown
- 2003-11-11 IS IS7027A patent/IS7027A/is unknown
- 2003-11-12 CO CO03100159A patent/CO5540303A2/es not_active Application Discontinuation
- 2003-11-17 NO NO20035115A patent/NO20035115D0/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005510457A5 (enExample) | ||
| JP2005508293A5 (enExample) | ||
| JP2005508292A5 (enExample) | ||
| RU2003131964A (ru) | Производные 4-(фенил-пиперазинил-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств | |
| JP2005505583A5 (enExample) | ||
| JP2006510716A5 (enExample) | ||
| JP2004520292A5 (enExample) | ||
| RU2002125495A (ru) | Гидроксифенил-пиперидин-4-илиден-метил-бензамидные производные для лечения боли | |
| RU2003131970A (ru) | Производные 4-(фенил-пиперидин-4-илиден-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств | |
| JP2005508858A5 (enExample) | ||
| RU2003131971A (ru) | Производные 4-(фенил-пиперидин-4-илиден-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств | |
| JP2003529598A5 (enExample) | ||
| JP2005507372A5 (enExample) | ||
| RU2004107854A (ru) | Производные 4[пиперидин-4-илиден-(3-карбомоилфенил)метил]бензамида и их применение для лечении боли, спинальных повреждений или желудочно-кишечных расстройств | |
| EP1246808A1 (de) | 1,2-diarylbenzimidazole zur behandlung von krankungen die mit einer microglia-aktivierung assoziiert sind | |
| US7517898B2 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| JP2003529597A5 (enExample) | ||
| RU2005121491A (ru) | Производные диарилметилиденпиперидина, их препараты и их применение | |
| JP2005508289A5 (enExample) | ||
| RU2003131969A (ru) | Производные 4-(фенил-пиперидин-4-илиден-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств | |
| RU2002125506A (ru) | Хинолинил-пиперидин-4-илиден-метил-бензамидные производные для лечения боли | |
| JP2006513222A5 (enExample) | ||
| JP2005510456A5 (enExample) | ||
| JP2005508290A5 (enExample) | ||
| JP2014521620A5 (enExample) |